Russell G. Postier

Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma

Benjamin J. Raphael, Ralph H. Hruban, Andrew J. Aguirre et al. · Cancer Cell · 2017 · 2.1K citations · Full text

Medicine, Genetics, Molecular Genetics +13

Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe Sepsis

Edward Abraham, Konrad Reinhart, Steven M. Opal et al. · JAMA · 2003 · 957 citations

Medicine, Pharmacology, Pharmacotherapy +15

Expression profiling identifies microRNA signature in pancreatic cancer

Eun Joo Lee, Yuriy Gusev, Jinmai Jiang et al. · International Journal of Cancer · 2006 · 906 citations · Full text

Medicine, Cancer Biology, Oncology +17

Factors affecting mortality in biliary tract surgery

Henry A. Pitt, John L. Cameron, Russell G. Postier et al. · The American Journal of Surgery · 1981 · 325 citations

Medicine, Perioperative Medicine, Surgery +11

Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study

Edward Abraham, Konrad Reinhart, Petr Svoboda et al. · Critical Care Medicine · 2001 · 253 citations

Medicine, Pharmacology, Pharmacotherapy +16